Mani K, Venermo M, Beiles B, Menyhei G, Altreuther M, Loftus I, Björck M
Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden.
Department of Vascular Surgery, Helsinki University Hospital, Helsinki, Finland.
Eur J Vasc Endovasc Surg. 2015 Jun;49(6):646-652. doi: 10.1016/j.ejvs.2015.01.021. Epub 2015 Mar 7.
OBJECTIVE/BACKGROUND: National differences exist in the outcome of elective abdominal aortic aneurysm (AAA) repair. The role of case mix variation was assessed based on an international vascular registry collaboration.
All elective AAA repairs with aneurysm size data in the Vascunet database in the period 2005-09 were included. AAA size and peri-operative outcome (crude and age adjusted mortality) were analysed overall and in risk cohorts, as well as per country. Glasgow Aneurysm Score (GAS) was calculated as risk score, and patients were stratified in three equal sized risk cohorts based on GAS. Predictors of peri-operative mortality were analysed with multiple regression. Missing data were handled with multiple imputation.
Patients from Australia, Finland, Hungary, Norway, Sweden and the UK (n = 5,895) were analysed; mean age was 72.7 years and 54% had endovascular repair (EVAR). There were significant variations in GAS (lowest = Finland [75.7], highest = UK [79.4], p for comparison of all regions < .001), proportion of AAA < 5.5 cm (lowest = UK [6.4%], highest = Hungary [29.0%]; p < .001), proportion undergoing EVAR (lowest = Finland [10.1%], highest = Australia [58.9%]; p < .001), crude mortality (lowest = Norway [2.0%], highest = Finland [5.0%]; p = .006), and age adjusted mortality (lowest = Norway [2.5%], highest = Finland [6.0%]; p = .048). Both aneurysm size and peri-operative mortality were highest among patients with a GAS >82. Of those with a GAS >82, 8.4% of men and 20.8% of women had an AAA <5.5 cm.
Important regional differences exist in case selection for elective AAA repair, including variations in AAA size and patient risk profile. These differences partly explain the variations in peri-operative mortality. Further audit is warranted to assess the underlying reasons for the regional variation in case-mix.
目的/背景:择期腹主动脉瘤(AAA)修复手术的结果存在国家间差异。基于一项国际血管登记协作评估了病例组合差异的作用。
纳入2005年至2009年期间Vascunet数据库中所有有动脉瘤大小数据的择期AAA修复手术。总体上以及在风险队列中,同时按国家分析AAA大小和围手术期结果(粗死亡率和年龄校正死亡率)。计算格拉斯哥动脉瘤评分(GAS)作为风险评分,并根据GAS将患者分为三个大小相等的风险队列。采用多元回归分析围手术期死亡率的预测因素。缺失数据采用多重填补法处理。
分析了来自澳大利亚、芬兰、匈牙利、挪威、瑞典和英国的患者(n = 5895);平均年龄为72.7岁,54%接受了血管腔内修复(EVAR)。GAS存在显著差异(最低为芬兰[75.7],最高为英国[79.4],所有地区比较的p <.001),AAA < 5.5 cm的比例(最低为英国[6.4%],最高为匈牙利[29.0%];p <.001),接受EVAR的比例(最低为芬兰[10.1%],最高为澳大利亚[58.9%];p <.001),粗死亡率(最低为挪威[2.0%],最高为芬兰[5.0%];p =.006),以及年龄校正死亡率(最低为挪威[2.5%],最高为芬兰[6.0%];p =.048)。GAS > 82的患者中,动脉瘤大小和围手术期死亡率均最高。在GAS > 82的患者中,8.4%的男性和20.8%的女性患有AAA < 5.5 cm。
择期AAA修复手术的病例选择存在重要的地区差异,包括AAA大小和患者风险特征的差异。这些差异部分解释了围手术期死亡率的差异。有必要进一步进行审核,以评估病例组合地区差异的潜在原因。